Business Context and Reporting Period
This Form 8-K was filed by Medical Transcription Billing, Corp. (MTBC) on August 30, 2017. The registrant is an emerging growth company incorporated in Delaware. The filing reports the entry into a material definitive agreement regarding a public offering of preferred stock.
Key Financial Metrics
The filing details a capital raise event rather than operational financial performance.
- Transaction Type: Public offering of 15,000 shares of 11% Series A Cumulative Redeemable Preferred Stock.
- Net Proceeds: Approximately $317,000 after deducting placement agency fees and estimated offering expenses.
- Underwriter: H.C. Wainwright & Co., LLC.
- Revenue, Profit, Cash Flow, Debt, and Margins: The filing text does not provide a clear value for these operational metrics.
Material Changes
The primary material change is the execution of a Placement Agency Agreement dated August 30, 2017, to issue and sell the preferred stock pursuant to a Registration Statement on Form S-3 (File No. 333-210391). No comparative period data is provided in this specific report.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the offering terms. The transaction involves the issuance of cumulative redeemable preferred stock, which carries specific dividend and redemption obligations not detailed in this summary text.
Investor Verification Checklist
- Verify the full terms of the 11% Series A Cumulative Redeemable Preferred Stock, including dividend payment schedules and redemption rights.
- Review the Placement Agency Agreement (Exhibit 1.1) for specific fee structures and conditions.
- Confirm the use of the $317,000 net proceeds as disclosed in the related press release (Exhibit 99.1).
- Check the Registration Statement on Form S-3 (File No. 333-210391) for the complete prospectus and offering details.